Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1675827

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 November to Question 881 on Bowel Cancer: Screening, what her planned timetable is for publishing a decision on lowering the screening age for bowel cancer from 60 to 50 years old.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	5575
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>NHS England started the lowering of age for bowel cancer screening in April 2021. The following table shows the rollout plan for the bowel screening:</p><table><tbody><tr><td><p>Cohort age at first invitation</p></td><td><p>Year invitations start</p></td></tr><tr><td><p>Age 56</p></td><td><p>2021/22</p></td></tr><tr><td><p>Age 58</p></td><td><p>2022/23</p></td></tr><tr><td><p>Age 54</p></td><td><p>2023/24</p></td></tr><tr><td><p>Age 50 and 52</p></td><td><p>2024/25</p></td></tr></tbody></table><p> </p><p>Note: The timeline may differ slightly from region to region</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 11/12/2023 16:50:11 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4571 label Biography information for Gill Furniss

1675828

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of limiting vape flavours to tobacco-flavoured devices on levels of smoking; and if she will bring forward legislative proposals to implement such a limitation.
tabling member constituency	Northampton South
tabling member printed	Andrew Lewer
uin	5576
answer	answer is ministerial correction date of answer 15/12/2023 answer text <p>Due to nicotine content and the unknown long-term harms, vaping carries risks to health and lifelong addiction for children. The health advice is clear that young people and people who have never smoked should not vape.</p><p>This is why the Government consulted on measures to reduce the appeal and availability of vapes to children. These measures will need to balance having the biggest impact on youth vaping with ensuring vapes continue to support adult smokers to quit.</p><p>The consultation response will be published shortly.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 15/12/2023 13:42:39 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4659 label Biography information for Andrew Lewer

1675842

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what steps her Department is taking to help ensure that people with less common conditions are not disproportionately impacted by additional rebates for older medicines.
tabling member constituency	Lincoln
tabling member printed	Karl McCartney
uin	5516
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Health Service patients benefit from cutting-edge treatments including personalised CAR-T cancer therapies, lifechanging treatments for rare conditions, and lifesaving gene therapies. The new voluntary scheme for branded medicines pricing, access and growth agreement will continue to build on these significant achievements, for example, through the piloting of new approaches for paying for ground-breaking advanced therapy medicinal products.</p><p>We do not expect disproportional impacts on people with less common conditions resulting from these policies. Provisions in the scheme allow for companies to apply for price increases should supply of products be otherwise uneconomical. Under specific circumstances an adjusted ‘Top-up Payment Percentage’ can also be considered for other older medicines where there would otherwise be a negative impact on patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 5518 question first answered 11/12/2023 16:12:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4028 label Biography information for Karl McCartney

1675843

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment her Department has made of the potential impact of these policies on life science SMEs.
tabling member constituency	Lincoln
tabling member printed	Karl McCartney
uin	5517
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>The Government’s Life Sciences Vision sets out our ambition to develop a globally competitive life sciences investment ecosystem in the United Kingdom. While no assessment has been made, the 2024 voluntary scheme for branded medicines pricing, access and growth includes several policies that will benefit innovative companies and drive innovation into the United Kingdom. This includes an exemption from payment for small companies with under £6m of sales to the National Health Service and a taper for medium sized companies with between £6 million and £30 million of sales.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 11/12/2023 16:10:36 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4028 label Biography information for Karl McCartney

1675844

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment her Department has made of the potential impact of these policies on people with less common conditions.
tabling member constituency	Lincoln
tabling member printed	Karl McCartney
uin	5518
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Health Service patients benefit from cutting-edge treatments including personalised CAR-T cancer therapies, lifechanging treatments for rare conditions, and lifesaving gene therapies. The new voluntary scheme for branded medicines pricing, access and growth agreement will continue to build on these significant achievements, for example, through the piloting of new approaches for paying for ground-breaking advanced therapy medicinal products.</p><p>We do not expect disproportional impacts on people with less common conditions resulting from these policies. Provisions in the scheme allow for companies to apply for price increases should supply of products be otherwise uneconomical. Under specific circumstances an adjusted ‘Top-up Payment Percentage’ can also be considered for other older medicines where there would otherwise be a negative impact on patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 5516 question first answered 11/12/2023 16:12:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4028 label Biography information for Karl McCartney

1675879

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Immunosuppression
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to provide covid-19 (a) tests and (b) treatment to immunocompromised patients in winter 2023-24.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	5532
answer	answer is ministerial correction date of answer 13/12/2023 answer text <p>As set out in the Written Ministerial Statement <a href="https://questions-statements.parliament.uk/written-statements/detail/2023-03-30/hcws702" target="_blank">HCWS702</a> on 30 March 2023, the UK Health Security Agency (UKHSA) will maintain a range of capabilities to protect those at higher risk of severe illness from COVID-19. We have retained appropriate levels of testing to support diagnosis for clinical care and treatment and to protect higher risk individuals. Those who are eligible for COVID-19 treatments can collect free rapid lateral flow test kits from a local pharmacy. Those who are immunocompromised are eligible for COVID-19 treatments and influenza antivirals in the community, enabling them easy access to treatment.</p><p>Higher risk individuals, their carers, and household contacts, are also part of the priority cohort in line for booster vaccines. UKHSA continues to encourage people to take vaccines they are eligible for, most recently via the ‘get winter strong’ campaign. More information on the campaign is available at the following link:</p><p><a href="https://www.gov.uk/government/news/ukhsa-campaign-get-winter-strong-with-flu-and-covid-19-vaccines" target="_blank">https://www.gov.uk/government/news/ukhsa-campaign-get-winter-strong-with-flu-and-covid-19-vaccines</a></p><p>Guidance for people whose immune system means they are at a higher risk of serious illness from COVID-19 is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk" target="_blank">https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/12/2023 17:34:47 answering member 4492 label Biography information for Maria Caulfield previous answer version 6688 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	4385 label Biography information for Dr Philippa Whitford

1675880

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, published on 7 January 2019, how much and what proportion of the additional £2.3 billion of funding for mental health services has been spent on services for (a) children and (b) other young people.
tabling member constituency	Twickenham
tabling member printed	Munira Wilson
uin	5578
answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>The NHS Long Term Plan committed to increasing funding to support the expansion and transformation of National Health Service-funded mental health services for adults, children, and young people in England by an additional £2.3 billion a year by March 2024. The proportion of this funding that has been spent on children and young people’s services is not separately identifiable.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/12/2023 16:09:01 answering member 4492 label Biography information for Maria Caulfield
tabling member	4776 label Biography information for Munira Wilson

1675881

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding her Department has provided for (a) mental health services (i) for children and young people and (ii) in total and (b) all NHS services in each financial year since 2019-20.
tabling member constituency	Twickenham
tabling member printed	Munira Wilson
uin	5579
answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>It is for individual local commissioners to allocate funding to mental health services to meet the needs of their local populations and this information is not collected centrally. Integrated care boards are expected to continue to meet the Mental Health Investment Standard by increasing their investment in mental health services in line with their overall increase in funding for the year.</p><p>The following table shows the actual expenditure on mental health services for the period 2019/20 to 2022/23:</p><table><tbody><tr><td><p>Year</p></td><td><p>Mental health spend for children and young people, excluding learning disabilities and eating disorders (£ billion)</p></td><td><p>Total mental health spend (£ billion)</p></td></tr><tr><td><p>2019/20</p></td><td><p>0.79</p></td><td><p>13.32</p></td></tr><tr><td><p>2020/21</p></td><td><p>0.88</p></td><td><p>14.31</p></td></tr><tr><td><p>2021/22</p></td><td><p>0.92</p></td><td><p>14.93</p></td></tr><tr><td><p>2022/23</p></td><td><p>1.04</p></td><td><p>15.97</p></td></tr></tbody></table><p>Source: NHS Mental Health Dashboard</p><p>Note: Total actual mental health spend reported here includes spending on learning disabilities and dementia, which is not included in the mental health investment standard or the baseline spend for the commitment in the NHS Long Term Plan to increase mental health spending by at least £2.3 billion a year by 2023/24.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/12/2023 16:10:20 answering member 4492 label Biography information for Maria Caulfield
tabling member	4776 label Biography information for Munira Wilson

1675924

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Workers: Migrant Workers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number and proportion of care workers who were born overseas that are (a) women and (b) men.
tabling member constituency	Kingston upon Hull North
tabling member printed	Dame Diana Johnson
uin	5552
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>Skills for Care data, published October 2023, shows that of the care workers recruited internationally since 2022, 68% were female and 32% were male. We do not hold data on the number of care workers born overseas.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 11/12/2023 17:33:33 answering member 4527 label Biography information for Helen Whately
tabling member	1533 label Biography information for Dame Diana Johnson

1675932

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help maintain the availability of (a) pharmacies and (b) medication.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	5606
answer	answer is ministerial correction date of answer 18/12/2023 answer text <p>The Department is closely monitoring changes to the pharmacy network to ensure access to the services they provide on behalf of the National Health Service. Access to services remains good with 80% of people in England living within 20 minutes walking distance of a pharmacy and twice as many pharmacies in the most deprived areas of the country. Patients can also choose to access NHS pharmaceutical services remotely through any of the approximately 400 internet pharmacies, who are contractually required to deliver medicines to patient home free of charge. Every three years, local authorities in England undertake pharmaceutical needs assessments for their areas to ensure provision continues to meet their population’s needs.</p><p>We have well-established processes for managing and mitigating medicine supply issues, which involve working with the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, NHS England, the devolved governments and others operating in the supply chain to help ensure patients have access to the treatments they need.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 18/12/2023 16:38:25 answering member 4117 label Biography information for Andrea Leadsom previous answer version 7026 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	4656 label Biography information for Layla Moran